ATE369840T1 - Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen - Google Patents
Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigenInfo
- Publication number
- ATE369840T1 ATE369840T1 AT02700887T AT02700887T ATE369840T1 AT E369840 T1 ATE369840 T1 AT E369840T1 AT 02700887 T AT02700887 T AT 02700887T AT 02700887 T AT02700887 T AT 02700887T AT E369840 T1 ATE369840 T1 AT E369840T1
- Authority
- AT
- Austria
- Prior art keywords
- itraconazole
- acid
- working solution
- particles
- coated particles
- Prior art date
Links
- 229960004130 itraconazole Drugs 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- VHVPQPYKVGDNFY-ZPGVKDDISA-N itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 abstract 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 6
- 239000002245 particle Substances 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 3
- 239000012224 working solution Substances 0.000 abstract 3
- 239000006186 oral dosage form Substances 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000011162 core material Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26665301P | 2001-02-06 | 2001-02-06 | |
| US09/933,032 US6663897B2 (en) | 2001-02-06 | 2001-08-20 | Oral itraconazole formulations and methods of making the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE369840T1 true ATE369840T1 (de) | 2007-09-15 |
Family
ID=26951964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02700887T ATE369840T1 (de) | 2001-02-06 | 2002-02-01 | Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6663897B2 (enExample) |
| EP (1) | EP1357899B1 (enExample) |
| JP (1) | JP2004521897A (enExample) |
| AT (1) | ATE369840T1 (enExample) |
| AU (1) | AU2002233822A1 (enExample) |
| CA (1) | CA2437372A1 (enExample) |
| DE (1) | DE60221795T2 (enExample) |
| MX (1) | MXPA03006980A (enExample) |
| WO (1) | WO2002062318A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015239D0 (en) * | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| US8071133B2 (en) | 2001-08-20 | 2011-12-06 | Stiefel Laboratories, Inc. | Oral dosage forms of water insoluble drugs and methods of making the same |
| US20040115266A1 (en) * | 2002-02-01 | 2004-06-17 | Namburi Ranga Raju | Oral itraconazole formulations and methods of making the same |
| US20050025791A1 (en) | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| WO2003074474A2 (en) | 2002-03-01 | 2003-09-12 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
| GB0205253D0 (en) * | 2002-03-06 | 2002-04-17 | Univ Gent | Immediate release pharmaceutical granule compositions and a continuous process for making them |
| EP1511490A4 (en) | 2002-05-31 | 2009-03-11 | Transform Pharmaceuticals Inc | NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED METHODS, PHARMACEUTICAL COMPOSITIONS AND METHODS |
| EP1539111A1 (en) * | 2002-08-05 | 2005-06-15 | DSM IP Assets B.V. | Oral dosage forms of water insoluble drugs and methods of making the same |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US20050074494A1 (en) * | 2003-10-06 | 2005-04-07 | Xiu-Xiu Cheng | Itraconazole immediate release formulation |
| US20050118265A1 (en) * | 2003-11-28 | 2005-06-02 | Anandi Krishnan | Antifungal oral dosage forms and the methods for preparation |
| GB0612695D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Gent | Process for preparing a solid dosage form |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791111A (en) | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| PH30929A (en) | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
| IT1263831B (it) | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
| NZ333514A (en) * | 1996-06-28 | 2000-05-26 | Schering Corp | Oral pharmaceutical composition comprising a triazole antifungal compound |
| FR2758461A1 (fr) | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
| WO1998042318A1 (en) * | 1997-03-26 | 1998-10-01 | Janssen Pharmaceutica N.V. | Pellets having a core coated with an antifungal and a polymer |
| DK1104291T3 (da) * | 1998-07-17 | 2006-01-16 | Janssen Pharmaceutica Nv | Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer |
| US7939105B2 (en) | 1998-11-20 | 2011-05-10 | Jagotec Ag | Process for preparing a rapidly dispersing solid drug dosage form |
| ATE307808T1 (de) | 1999-03-24 | 2005-11-15 | Scherer Technologies Inc R P | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| KR100331529B1 (ko) | 1999-06-16 | 2002-04-06 | 민경윤 | 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법 |
-
2001
- 2001-08-20 US US09/933,032 patent/US6663897B2/en not_active Expired - Lifetime
-
2002
- 2002-02-01 EP EP02700887A patent/EP1357899B1/en not_active Expired - Lifetime
- 2002-02-01 AT AT02700887T patent/ATE369840T1/de not_active IP Right Cessation
- 2002-02-01 CA CA002437372A patent/CA2437372A1/en not_active Abandoned
- 2002-02-01 DE DE60221795T patent/DE60221795T2/de not_active Expired - Fee Related
- 2002-02-01 MX MXPA03006980A patent/MXPA03006980A/es active IP Right Grant
- 2002-02-01 AU AU2002233822A patent/AU2002233822A1/en not_active Abandoned
- 2002-02-01 WO PCT/NL2002/000080 patent/WO2002062318A2/en not_active Ceased
- 2002-02-01 JP JP2002562325A patent/JP2004521897A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004521897A (ja) | 2004-07-22 |
| DE60221795D1 (de) | 2007-09-27 |
| MXPA03006980A (es) | 2004-10-15 |
| US6663897B2 (en) | 2003-12-16 |
| DE60221795T2 (de) | 2007-12-27 |
| US20020150620A1 (en) | 2002-10-17 |
| EP1357899A2 (en) | 2003-11-05 |
| EP1357899B1 (en) | 2007-08-15 |
| AU2002233822A1 (en) | 2002-08-19 |
| CA2437372A1 (en) | 2002-08-15 |
| WO2002062318A2 (en) | 2002-08-15 |
| WO2002062318A3 (en) | 2002-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60221795D1 (de) | Orale zusammensetzungen von itraconazol und verfahren zu herstellung derselbigen | |
| DE60219319D1 (de) | Trockene hämostatische zusammensetzungen und verfahren zu ihrer herstellung | |
| DE50110049D1 (de) | Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung | |
| DE69906269D1 (de) | Wässriges verfahren zur herstellung fester paroxetin-dispersionen | |
| DE60100186D1 (de) | Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung | |
| ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
| SE7611379L (sv) | Antihypertensiva medel | |
| DE60138362D1 (de) | Bioadhäsive zusammensetzung | |
| DE60023841D1 (de) | Verfahren zur herstellung alkylierter salicylamide | |
| DE69132497D1 (de) | Benzimidazolderivate, verfahren zu deren herstellung und deren anwendung | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| DE60102850T2 (de) | Verfahren zur Herstellung von wässrigen Beschichtungszusammensetzungen | |
| ATE554059T1 (de) | Getriggerte startprodukte und verfahren zu ihrer herstellung und verwendung | |
| PT992509E (pt) | Novos derivados macrolidos | |
| WO2002043706A3 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
| CY1106376T1 (el) | Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν | |
| ES2058963T3 (es) | Dihidropiridinas substituidas heterociclicamente, procedimiento para su fabricacion y su uso en medicamentos. | |
| NO20004919D0 (no) | FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater | |
| DE69813565D1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| IT1256623B (it) | Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche | |
| DE60119905D1 (de) | Verfahren zur herstellung fester dispersionen | |
| DE50205794D1 (de) | Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat | |
| DK1392672T3 (da) | Chlormethylering af thiopen | |
| EP1842532A3 (en) | Oral sparingly water-soluble antifungal formulations and methods of making the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |